Statistically significant (p<0.0001) and clinically meaningful improvement in Hamilton Anxiety Rating Scale (“HAM-A”) of ~10 ...
A new synthesis finds that common epilepsies are driven by thousands of tiny-effect genetic variants, most still ...
People affected by human immunodeficiency virus (HIV), which causes AIDS, did not develop more severe forms of mpox than HIV-negative people during the multiregional outbreak of this disease that ...
An insightful mini-review published in Genomic Psychiatry synthesizes the rapidly expanding landscape of molecular genetic research on common epilepsies, assembling evidence from genome-wide ...
RAP-219’s lead program demonstrated robust and consistent activity in patients with focal onset seizures (FOS) in Phase 2a trial; initiation of ...
Abstract: Generalized Zero-Shot Learning (GZSL) aims at recognizing images from both seen and unseen classes by constructing correspondences between visual images and semantic embedding. However, ...
The bipolar depression market is anticipated to increase during the forecast period (2026--2036), owing to the rise in the launch of emerging therapies such as Azetukalner (Xenon Pharmaceuticals), ...
Abstract: Remote sensing images are essential for many applications of the Earth’s sciences, but their quality can usually be degraded due to limitations in sensor technology and complex imaging ...
Trump policy initiatives that generated those challenges for businesses — along with non-cited disruptions like import tariffs, increasingly tense international relations, and now-fulfilled threats of ...
Shanghai-based Tenacia Biotechnology is making a $308 million biobucks move for Rapport Therapeutics' leading asset focused on focal onset seizures (FOS) and primary generalized tonic-clonic seizures, ...
My wife “Anna” and I are mired in an argument over something that is a complete non-issue. We have two kids, “Molly,” 7, and ...
Hawks at the European Central Bank are eager to change history. The energy price shock this month may not be as severe as the ...